Loading...

Most Recent

Agriculture faculty members allege funding from industry organizations is tied to their employment status.

0 Comments

image: Image of the Day: Tadpole Prism

Image of the Day: Tadpole Prism

By The Scientist Staff | November 3, 2017

Scientists are making use of Xenopus tadpoles to study autism risk genes. 

0 Comments

image: Corals’ pH Sensor Identified

Corals’ pH Sensor Identified

By Ashley P. Taylor | November 1, 2017

Soluble adenylyl cyclase measures and responds to pH changes in coral cells, but whether it can help the animals withstand ocean acidification is not yet known.

0 Comments

image: Opinion: How to Define Cell Type

Opinion: How to Define Cell Type

By Sara B. Linker, Tracy A. Bedrosian, and Fred H. Gage | November 1, 2017

Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.

0 Comments

image: Infographic: Breaking into the Brain

Infographic: Breaking into the Brain

By Amanda B. Keener | November 1, 2017

The blood-brain barrier is a collection of specialized cells and proteins that control the movement of molecules from the blood to the central nervous system.

2 Comments

image: Getting Drugs Past the Blood-Brain Barrier

Getting Drugs Past the Blood-Brain Barrier

By Amanda B. Keener | November 1, 2017

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

3 Comments

image: Pesticide Residues Linked to Unsuccessful IVF

Pesticide Residues Linked to Unsuccessful IVF

By Kerry Grens | October 30, 2017

Women who ate more produce known to harbor pesticides were less likely to succeed with fertility treatment than women who ate fewer of these fruits and vegetables.

3 Comments

Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. RNA Injection Restores Hearing in Guinea Pigs
  4. Jim Bridenstine Confirmed to Lead NASA